EUVIMEDEUVIMED entdecken
Crossref

Oxygen‐Independent Synchronized ROS Generation and Hypoxia Prodrug Activation with Z‐Scheme Heterostructure Sonosensitizer

Yining Chen, Tianshu Zou, Gaoying Xin, Xin Liu, Yunan Yang, Liqi Wei, Biao Zhang, Pengcheng Yu, Yiping Ren, Yanlin Feng, Rui Chen iD, Fangfang Cao iD und 2 weitere

Advanced Materials · 2024

DOI: 10.1002/adma.202307929 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Yining Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, College of Life Science, Jilin Agricultural Universi…. Hauptthemen laut MEDLINE: Prodrugs, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Development Project Foundation of Jilin Province, Program of Jilin Provincial Development and Reform Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Combination therapy has emerged as a promising approach for effective tumor treatment. However, the combination of sonodynamic therapy (SDT) and hypoxia‐activated prodrugs (HAPs) has not been explored due to the contradictory requirement of oxygen (O 2 ) for reactive oxygen species (ROS) generation and the necessity to avoid O 2 for the activation of HAPs. In this study, this challenge is addressed by developing BiOCl‐Au‐Ag 2 S Z‐scheme heterostructure nanoparticles loaded with tirapazamine (TPZ) to achieve O 2 ‐independent therapy. These nanoparticles demonstrate efficient electron–hole separation under ultrasound irradiation while maintaining a high redox potential. The generated holes react with water to efficiently produce hydroxyl radicals, while the electrons autonomously activate TPZ, negating the need for O 2 . In vitro and in vivo assessments validate the effective tumor elimination by these Z‐scheme nanoparticles without disrupting the hypoxic environment. This innovative design overcomes the limitations associated with O 2 requirement in SDT and introduces a novel strategy for HAP activation and synergistic therapy between ROS and HAPs‐based therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsNeoplasmsNanoparticlesHumansOxygenReactive Oxygen SpeciesTirapazamineHypoxiaCell Line, Tumor

Stichwörter der Autor:innen

Z-scheme heterostructurehypoxia-activated prodrugsoxygen-independent synergistic therapysonodynamic therapy

Substanzen

OxygenReactive Oxygen SpeciesProdrugsTirapazamine

Autor:innen und Institutionen

  • Engineering Research Center of Bioreactor and Pharmaceutical Development, Ministry of Education, College of Life Science, Jilin Agricultural University, Changchun, 130118, P. R. China.
  • Jilin Provincial Key Laboratory of Human Health Status Identification and Function Enhancement, College of Science, Changchun University, Changchun, 130022, P. R. China.
  • Key Laboratory of Cellular Physiology at Shanxi Medical University, Ministry of Education, and the Department of Physiology, Shanxi Medical University, Taiyuan, 030001, P. R. China.
  • Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, Singa…
  • Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.
  • Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.

ORCID-Profile: Rui Chen, Fangfang Cao, Xiaoyuan Chen, Yan Cheng

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Development Project Foundation of Jilin Province
  • Program of Jilin Provincial Development and Reform Commission
  • National University of Singapore
  • National Medical Research Council
  • Singapore Ministry of Education
  • National Research Foundation

Zitieren

APA

Chen, Y., Zou, T., Xin, G., Liu, X., Yang, Y., Wei, L., Zhang, B., Yu, P., Ren, Y., Feng, Y., Chen, R., Cao, F., Chen, X., & Cheng, Y. (2024). Oxygen‐Independent Synchronized ROS Generation and Hypoxia Prodrug Activation with Z‐Scheme Heterostructure Sonosensitizer. Advanced Materials. https://doi.org/10.1002/adma.202307929

Vancouver

Chen Y, Zou T, Xin G, Liu X, Yang Y, Wei L, et al. Oxygen‐Independent Synchronized ROS Generation and Hypoxia Prodrug Activation with Z‐Scheme Heterostructure Sonosensitizer. Advanced Materials. 2024. doi:10.1002/adma.202307929

BibTeX
@article{Chen2024,
  author = {Chen, Yining and Zou, Tianshu and Xin, Gaoying and Liu, Xin and Yang, Yunan and Wei, Liqi and Zhang, Biao and Yu, Pengcheng and Ren, Yiping and Feng, Yanlin and Chen, Rui and Cao, Fangfang and Chen, Xiaoyuan and Cheng, Yan},
  title = {Oxygen‐Independent Synchronized ROS Generation and Hypoxia Prodrug Activation with Z‐Scheme Heterostructure Sonosensitizer},
  journal = {Advanced Materials},
  year = {2024},
  doi = {10.1002/adma.202307929}
}
Kostenlos starten →